Unit 5: Section 1 Flashcards
Hep A: mode of transmission, clinical syndromes, incubation periods, risk for development of chronic hepatitis, and distinctions related to epidemiology.
Transmission: Fecal, oral
Incubation period: about 28 days
Clinical syndromes: acute illness, self-limited
Risk for development of chronic: Very unlikely
Distinctions:Associated with outbreaks, general decline in US with slight recent increase, VACCINE
Hep B: mode of transmission, clinical syndromes, incubation periods, risk for development of chronic hepatitis, and distinctions related to epidemiology.
Transmission: Parenteral, sexual and perinatal
Incubation period: About 2-3 months
Clinical syndromes:
Risk for development of chronic: unlikely: age dependent-infants and children at greatest risk
Distinctions: Highly contagious with recent leveling/decline, VACCINE
Hep C: mode of transmission, clinical syndromes, incubation periods, risk for development of chronic hepatitis, and distinctions related to epidemiology.
Transmission: Usually parenteral, perinatal, rare STI
Incubation period: About 7 weeks
Clinical syndromes: Chronic liver disease and cirrhosis
Risk for development of chronic: 75-85%
Distinctions: Not highly contagious; No vaccine; increasing
Hep D: mode of transmission, clinical syndromes, incubation periods, risk for development of chronic hepatitis, and distinctions related to epidemiology.
Transmission: Usually parenteral, also perinatal and sexual
Incubation period: 21-49 days
Clinical syndromes: Requires HBV for replication/expression of its RNA; possible superinfection–>chronic liver disease, cirrhosis and liver failure
Risk for development of chronic: Low risk
Distinctions: recent leveling/decline
Hep E: mode of transmission, clinical syndromes, incubation periods, risk for development of chronic hepatitis, and distinctions related to epidemiology.
Transmission: Fecal, oral Incubation period: About 40 days Clinical syndromes: Acute, self-limiting Risk for development of chronic: None Distinctions: Prevalent in developing world; high mortality rate for pregnant women
Describe the immune response to viral infection
TLRs help recognize virus as non-self–>Type 1 interferon production triggered–>Inhibit viral replication, activate NK cells, enhances MHC I expression
Antibodies neutralize
Ab-dependent cell-mediated cytotoxicity
Complement activation
Describe 4 mechanisms used by viruses to evade the immune system.
1) Frequent genetic mutation-antigenic shift
2) Specific mechanisms to evade host defenses- interferons, complement
3) Direct suppression of host immune system- down regulate MHC
4) Evade detection by remaining latent
IgM anti-HAV: principle and diagnostic significance
IgM against Hep A virus; Screening
Total anti-HAV: principle and diagnostic significance
All antibodies against Hep A virus; Screening
HBsAg: principle and diagnostic significance
Hep B surface antigen; Screening; Indicates active infection
anti-HBs: principle and diagnostic significance
Antibody to hep B surface antigen; Screening; recovery/immunity from infection
anti-HBc: principle and diagnostic significance
Antibody to Hep B core antigen ; previous or ongoing infection
IgM anti-HBc: principle and diagnostic significance
IgM against Hep B core antigen; Screening; acute infection or recent infection
HBeAg: principle and diagnostic significance
Hep B envelope antigen; virus is replicating/ high viral load
anti-HBe: principle and diagnostic significance
Antibody against Hep B envelope; recovering from infection